Ftse Mib
34.908,72
0,15%
DAX
20.457,71
0,14%
S&P 500
6.051,25
-0,54%
NASDAQ
19.902,84
-0,66%
Bitcoin
100.231,89
0,17%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oric Pharmaceuticals Inc (ORIC) Oric Pharmaceuticals Inc (ORIC) Notizie

Oric Pharmaceuticals Inc

ORIC
8,43
0,00 (0,00%)
13 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/11/202422:15GLOBEORIC® Pharmaceuticals to Participate in Upcoming Investor..
14/11/202423:47EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:10EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEORIC® Pharmaceuticals Reports Third Quarter 2024 Financial..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202422:15GLOBEORIC® Pharmaceuticals to Participate in Upcoming Investor..
01/11/202421:30GLOBEORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq..
23/10/202413:00GLOBEORIC® Pharmaceuticals Presents Data Further Supporting..
09/10/202422:15GLOBEORIC® Pharmaceuticals Announces Presentation at the..
04/10/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
06/9/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
26/8/202422:05GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
12/8/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:10EDGAR2Form 8-K - Current report
12/8/202422:05GLOBEORIC Pharmaceuticals Reports Second Quarter 2024 Financial..
05/8/202422:15GLOBEORIC Pharmaceuticals Expands Leadership Team with the..
02/8/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
16/7/202422:59GLOBEORIC Pharmaceuticals Announces Multiple Clinical..
09/7/202413:30GLOBEAttovia Therapeutics Announces Election of Mitchell Gold and..
05/7/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
14/6/202422:05EDGAR2Form 8-K - Current report
07/6/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
29/5/202422:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
06/5/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:10EDGAR2Form 8-K - Current report
06/5/202422:05GLOBEORIC Pharmaceuticals Reports First Quarter 2024 Financial..
03/5/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
15/4/202422:15GLOBEORIC Pharmaceuticals Announces First Patients Dosed Across..
08/4/202414:00GLOBEORIC Pharmaceuticals Presents Preclinical Data on Two..
05/4/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
04/4/202422:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
11/3/202422:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/3/202421:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202421:10EDGAR2Form 8-K - Current report
11/3/202421:05GLOBEORIC Pharmaceuticals Reports Fourth Quarter and Full Year..
06/3/202422:30GLOBEORIC Pharmaceuticals to Present at the Leerink..
05/3/202422:30GLOBEORIC Pharmaceuticals Announces Multiple Presentations at the..
01/3/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
14/2/202422:30GLOBEORIC Pharmaceuticals to Participate in the Citi 2024 Virtual..
05/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/2/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
31/1/202422:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
26/1/202422:58EDGAR2Form S-3 - Registration statement under Securities Act of..
25/1/202419:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/1/202415:01EDGAR2Form 8-K - Current report
22/1/202414:30GLOBEORIC Pharmaceuticals Announces $125 Million Private..
09/1/202415:00EDGAR2Form 8-K - Current report
08/1/202414:30GLOBEORIC Pharmaceuticals Provides Initial Phase 1b Data for..
02/1/202422:30GLOBEORIC Pharmaceuticals to Present at the 42nd Annual J.P...
Apertura: Min: Max:
Chiusura: 8,43

La tua Cronologia

NASDAQ
ORIC
Oric Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network